+1.74%
Today
Loading 1D prices…
Company profile
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Sector
Health Care
Industry
Industrial Organic Chemicals
Exchange
Nasdaq
Display currency
USD
Location
Redwood City, CA, United States
Employees
146
Fiscal year end
1231
CIK
1200375
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| SAFXXCF Global Inc. Class A Common Stock | $168.9M | $20.8M | +355.52% | $0.52 | -1.20% | Hold |
| AMTXAemetis Inc. (DE) Common Stock | $145.1M | $208M | -37.02% | -$1.28 | -0.99% | Buy |
| LODEComstock Inc. Common Stock | $214.3M | $1.6M | -2778.16% | -$1.17 | -4.41% | Hold |
| FFFutureFuel Corp. Common shares | $239.9M | $95.7M | -51.59% | -$1.13 | +2.24% | Unrated |
| ALTOAlto Ingredients Inc. Common Stock | $302.5M | $917.9M | +0.00% | $0.16 | -1.64% | Buy |